Evidence map›Paper›PMID 40926865›Full record

ArticleVeterinary world2025

Seroprevalence and regional risk assessment of bluetongue virus among livestock in Central Saudi Arabia.

Roua A Alsubki

Abstract read
In one paragraph

Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Roua A AlsubkiDepartment of Clinical Laboratory Science, Chair of Medical and Molecular Genetics Research, College of Applied Medical Science, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Bluetongue virus (BTV), an arbovirus of major economic importance, affects domestic and wild ruminants globally and is primarily transmitted by Culicoides biting midges. The virus is endemic in many regions, yet limited data are available for Saudi Arabia. This study aimed to determine the seroprevalence of BTV antibodies in cattle, goats, sheep, and camels across two ecologically distinct regions in central Saudi Arabia and to assess species- and region-specific risk profiles. Materials and Methods: A total of 1,194 serum samples were collected from apparently healthy livestock (280 cattle, 159 camels, 429 sheep, and 326 goats) in Riyadh and Al-Qassim between October 2023 and March 2024. Samples were tested for BTV antibodies using a commercial competitive enzyme-linked immunosorbent assay. Statistical analysis included Chi-square tests and odds ratios with 95% confidence intervals to compare prevalence rates between species and regions. Results: The overall BTV seroprevalence was 44.6% (533/1,194). Goats had the highest prevalence (59.8%), followed by cattle (51%), sheep (36.3%), and camels (22.6%). In Riyadh, cattle (55.7%) and goats (55%) showed the highest rates, while in Al-Qassim, goats (65.7%) were most affected. Camels consistently showed the lowest seroprevalence (18.6%-25%). Statistically significant differences in seroprevalence were observed among species and between regions (p < 0.05). Conclusion: BTV is endemic in central Saudi Arabia, with substantial species and regional variability. Goats and cattle are at higher risk, indicating a need for species-targeted surveillance and vector control. The findings support the implementation of national bluetongue monitoring strategies and lay the groundwork for future molecular and longitudinal studies.

Indexed as

bluetongue viruscamelscattleCulicoidesenzyme-linked immunosorbent assaygoatslivestockSaudi Arabiaseroprevalence

Identifiers

PMID40926865
PMCPMC12415151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.